Videos
PANEL DISCUSSION: How are we faring as a country in our COVID19 Response?
1. Jonas del Rosario, MD (Patient)
2. Rabindra Abeyasinghe, MD, MSc, DTM&H (Public Health)
3. Nina Castillo-Carandang, MSc, PhD (Social Scientist)
4. Prof. Winnie Monsod, MA (Economist)
5. Maria Rosario S. Vergeire, MD, MPH, CESO IV (Government)
Moderators: Kathryn U. Roa, MD, FPCP, FPSMID & Bryan Albert Lim, MD, FPCP, FPSMID
The Philippine Society for Microbiology and Infectious Diseases (PSMID) Guidance on the Management of Mpox, Ver. 1 provides the basic and most updated information on management of patients confirmed with mpox.
This guidance complements the mpox recommendations of the DOH (Updated Interim Guidelines on the Prevention, Detection, and Management of MPOX, by Department of Health, August 26, 2024, Department Memorandum 2024-0306) and PHICS-PHICNA (Interim Guidelines on the Prevention and Control of Monkeypox version 1).
The antivirals, immunoglobulin and vaccines discussed below are not available locally. In our local situation, we should maximize supportive care for mpox cases.